Literature DB >> 24658529

Large retroperitoneal low-grade extraskeletal osteosarcoma.

Jiten Jaipuria1, Ashok Kumar, Adla Satyanarayan Rao, Satya Pal Kataria.   

Abstract

Low-grade extraskeletal osteosarcoma is an extremely rare neoplasm with only nine cases reported in the literature, in which only one case involved the retroperitoneum. Tendency to dedifferentiate as well as recur with high-grade variant is known and management principles are not well defined, necessitating a continuous review of literature. We report management of the largest such retroperitoneal tumour (18.0 cm × 18.3 cm × 17.8 cm) in a 38-year-old man, which was treated with surgery followed by six cycles of cisplatin (90 mg/m(2) days 1 and 2) and doxorubicin (75 mg/m(2) day 3), cycled every 3 weeks (with granulocyte colony stimulating factor support as necessary). The patient is disease free after 3 years of follow-up.

Entities:  

Mesh:

Year:  2014        PMID: 24658529      PMCID: PMC3962964          DOI: 10.1136/bcr-2014-203745

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

Review 1.  A low-grade extraskeletal osteosarcoma.

Authors:  Kyoji Okada; Hiroki Ito; Naohisa Miyakoshi; Masato Sageshima; Jun Nishida; Eiji Itoi
Journal:  Skeletal Radiol       Date:  2002-11-21       Impact factor: 2.199

2.  Ossifying fibrosarcoma (extraskeletal osteogenic sarcoma) of thigh muscle; report of a case with recurrence and widespread metastases more than four and a half years after excision.

Authors:  W UMIKER; H L JAFFE
Journal:  Ann Surg       Date:  1953-11       Impact factor: 12.969

3.  Primary intracerebral osteosarcoma: a case report.

Authors:  G S Bauman; W M Wara; S F Ciricillo; R L Davis; S Zoger; M S Edwards
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

4.  Case report 565: Low-grade osteosarcoma of soft tissues (popliteal fossa).

Authors:  D Present; F Bertoni; M Laus; P Bacchini; M Bocanera
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

5.  Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature.

Authors:  Renaud Sabatier; Corinne Bouvier; Gonzague de Pinieux; Anthony Sarran; Isabelle Brenot-Rossi; Florence Pedeutour; Bruno Chetaille; Patrice Viens; Pierre-Jean Weiller; François Bertucci
Journal:  BMC Cancer       Date:  2010-11-24       Impact factor: 4.430

6.  Primary extraskeletal osteosarcoma of omentum majus.

Authors:  Shui-Xiang Tao; Guo-Qin Tian; Meng-Hua Ge; Cheng-Long Fan
Journal:  World J Surg Oncol       Date:  2011-02-19       Impact factor: 2.754

7.  Well-differentiated extraskeletal osteosarcoma: report of 2 cases, 1 with dedifferentiation.

Authors:  Luigia C Abramovici; Prodromos Hytiroglou; Robert M Klein; Georgios Karkavelas; Antonios Drevelegas; Eugenia Panousi; German C Steiner
Journal:  Hum Pathol       Date:  2005-04       Impact factor: 3.466

8.  Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma.

Authors:  Sing Yu Goldstein-Jackson; Georg Gosheger; Günter Delling; Wolfgang E Berdel; G Ulrich Exner; Gernot Jundt; Jan-Nicolas Machatschek; Andreas Zoubek; Heribert Jürgens; Stefan S Bielack
Journal:  J Cancer Res Clin Oncol       Date:  2005-05-26       Impact factor: 4.553

9.  Well-differentiated extraskeletal osteosarcoma arising from the retroperitoneum that recurred as anaplastic spindle cell sarcoma.

Authors:  Hiromasa Arai; Yasushi Rino; Teppei Nishii; Norio Yukawa; Nobuyuki Wada; Hisashi Oshiro; Tsuyoshi Ishida; Noboru Nakaigawa; Munetaka Masuda
Journal:  Case Rep Med       Date:  2010-03-04

Review 10.  Well-differentiated extraskeletal osteosarcoma. A soft-tissue homologue of parosteal osteosarcoma.

Authors:  E S Yi; B M Shmookler; M M Malawer; D E Sweet
Journal:  Arch Pathol Lab Med       Date:  1991-09       Impact factor: 5.534

  10 in total
  1 in total

Review 1.  Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 2-Uncommon Sarcomas.

Authors:  Angela D Levy; Maria A Manning; Markku M Miettinen
Journal:  Radiographics       Date:  2017 May-Jun       Impact factor: 5.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.